Raymond James Trust N.A. Abbott Laboratories Transaction History
Raymond James Trust N.A.
- $4.22 Billion
- Q2 2024
A detailed history of Raymond James Trust N.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Raymond James Trust N.A. holds 209,265 shares of ABT stock, worth $23.8 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
209,265
Previous 205,691
1.74%
Holding current value
$23.8 Million
Previous $23.4 Million
6.99%
% of portfolio
0.52%
Previous 0.57%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,131Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.47 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.18 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.52 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...